CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Innate Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 24, 2021Neutralization Of Inhibitory Pathways In Lymphocytes1
Nov 4, 2020Cross Reactive Siglec Antibodies1

Top competitors of Innate Pharma

Top competitors of Innate Pharma based on patent oppositions.